Literature DB >> 25073511

miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.

Ying Ma1, Xing-guo She, Ying-zi Ming, Qi-quan Wan.   

Abstract

Accumulating evidence shows that microRNAs (miRNAs) are involved in the development and progression of multiple tumors, including hepatocellular carcinoma (HCC). Recent studies have found that miR-24 acts as an oncogene in several tumors; however, the function of miR-24 in HCC remains unclear. In this study, we found that miR-24 was increased in HCC tissues and cell lines. Inhibition of miR-24 by inhibitor significantly suppressed HCC cells proliferation, migration, and invasion. Furthermore, the sex-determining region Y (SRY)-box 7 (SOX7), a putative tumor suppressor, was found to be a target of miR-24 in HCC cells. Forced expression of SOX7 substantially attenuated the oncogenic effects of miR-24. Those results strongly suggest that miR-24 plays important role in HCC development partially by targeting SOX7.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25073511     DOI: 10.1007/s13277-014-2018-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).

Authors:  Xianchun Duan; Jianpeng Hu; Yongzhong Wang; Jiarong Gao; Daiyin Peng; Lunzhu Xia
Journal:  Gene       Date:  2014-03-11       Impact factor: 3.688

2.  Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.

Authors:  Yang Ke; Weiyong Zhao; Jie Xiong; Rubo Cao
Journal:  FEBS Lett       Date:  2013-08-13       Impact factor: 4.124

3.  Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer.

Authors:  Tindara Franchina; Valeria Amodeo; Giuseppe Bronte; Giuseppina Savio; Giuseppina R R Ricciardi; Maria Picciotto; Antonio Russo; Antonio Giordano; Vincenzo Adamo
Journal:  J Cell Physiol       Date:  2014-01       Impact factor: 6.384

Review 4.  SOX7: from a developmental regulator to an emerging tumor suppressor.

Authors:  Daniel B Stovall; Paul Cao; Guangchao Sui
Journal:  Histol Histopathol       Date:  2013-11-29       Impact factor: 2.303

Review 5.  microRNAs: a new class of breast cancer biomarkers.

Authors:  Laoighse Mulrane; Rut Klinger; Sharon F McGee; William M Gallagher; Darran P O'Connor
Journal:  Expert Rev Mol Diagn       Date:  2014-04       Impact factor: 5.225

6.  Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.

Authors:  Alessandro Salvi; Edoardo Abeni; Nazario Portolani; Sergio Barlati; Giuseppina De Petro
Journal:  Int J Oncol       Date:  2012-11-28       Impact factor: 5.650

7.  MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.

Authors:  Ting-Fang Lo; Wei-Chung Tsai; Shui-Tein Chen
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

8.  Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma.

Authors:  Geng-Gang Wu; Wen-Hong Li; Wen-Guang He; Nan Jiang; Guang-Xian Zhang; Wei Chen; Hai-Feng Yang; Qi-Long Liu; Yan-Nian Huang; Lei Zhang; Tong Zhang; Xian-Cheng Zeng
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

9.  Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studies.

Authors:  Jie Yang; Jia-yi Zhang; Jing Chen; Yang Xu; Ning-hong Song; Chang-jun Yin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.

Authors:  Angela M Liu; Zhi Xu; Felix H Shek; Kwong-Fai Wong; Nikki P Lee; Ronnie T Poon; Jinfei Chen; John M Luk
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more
  24 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

2.  APEX1/miR-24 axis: a promising therapeutic target in endometriosis.

Authors:  Aili Tan; Peng Ruan; Pengxing Sun
Journal:  Arch Gynecol Obstet       Date:  2021-01-27       Impact factor: 2.344

3.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

4.  Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.

Authors:  Bin Wang; JiaQing Fang; Lei Qu; Zhongwei Cao; JianGuo Zhou; Biao Deng
Journal:  Tumour Biol       Date:  2015-04-08

Review 5.  A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.

Authors:  Laurent Ehrlich; Chad Hall; Fanyin Meng; Terry Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  Gene Expr       Date:  2017-04-28

6.  Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.

Authors:  Jing Shen; Abby B Siegel; Helen Remotti; Qiao Wang; Regina M Santella
Journal:  Hepatoma Res       Date:  2016-06-01

7.  MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.

Authors:  Jie Chai; Shan Wang; Dali Han; Wei Dong; Chao Xie; Hongliang Guo
Journal:  Tumour Biol       Date:  2014-10-30

8.  Evaluation of the mirn23a Cluster through an iTRAQ-based Quantitative Proteomic Approach.

Authors:  Katelyn R Ludwig; Richard Dahl; Amanda B Hummon
Journal:  J Proteome Res       Date:  2016-04-06       Impact factor: 4.466

9.  MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.

Authors:  Ruyi Zhang; Shujuan Yan; Jing Wang; Fang Deng; Yangliu Guo; Ya Li; Mengtian Fan; Qilin Song; Hongxia Liu; Yaguang Weng; Qiong Shi
Journal:  Tumour Biol       Date:  2015-10-09

10.  Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.

Authors:  Huaiqi Yao; Xuanzhi Liu; Suzuan Chen; Wei Xia; Xiaojun Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.